Results with Lifescozul™Thyroid Cancer
Introduction to the case
Cancer can affect anyone, it does not discriminate in terms of race, color, status. It is a disease that can appear suddenly and in some cases takes 10 years to develop symptoms.
Cancer of the thyroid, the butterfly-shaped gland at the base of the neck, is relatively unknown and may be due to a combination of environmental and genetic factors.
There have been reports of people who have not developed any symptoms and others tend to notice a lump in the neck.
Effective treatments include surgery, hormone therapy, radioactive iodine, radiation and, in some cases, chemotherapy.
Today's case is still undergoing treatment and has been for more than 2 years with very positive results, but the disease is still present.
For the LifEscozul Group (escozul, blue scorpion venom) it has also been a challenge, since the patient Reyna decided not to undergo any conventional treatment. She has only been on LifEscozul, the most effective and certified formulation, made with blue scorpion venom.
Reyna Elena Langarica Borrá, 47 years old at the beginning of treatment with LifEscozul.
Occasional mild neck pain
October 20, 2018.
Papillary thyroid carcinoma with left lobe-dependent mass and left cervical adenopathy
In October 2017 Reyna went to the doctor in her home country for presenting dysphagia and progressive enlargement of the left side of the neck.
On examination she was found to have a mass in the left thyroid lobe and cervical lymphadenopathy on the same side, confirmed in April 2018 to be papillary thyroid carcinoma.
Reyna contacts us in October 2018, with the decision not to perform any conventional treatment and that was taken into account by our Medical Group when she was evaluated for use of LifEscozul.
The indicated dosage of LifEscozul, the most effective formulation made with blue scorpion venom (Escozul), was established in increasing cycles and with periodic controls. A direct physician was also assigned to the case from the beginning.
Evolution with LifEscozul™ and actual results
In October 2018 Reyna started treatment with LifEscozul. At that time her left thyroid lobe measured 43x16x20mm, at the expense of tumor presence and was intermittently painful.
One of the first indicators we measure is pain. If it is present or if it is not present, quantifying its intensity is vital to determine the degree of efficiency that the recommended dosing is having on the disease.
By December, two months after starting treatment with LifEscozul, Reyna told us that she no longer had pain. The intermittent episodes of pain were completely gone.
That was a very good sign that we were on the right track.
Subsequently in every communication during that year, the reports that Reyna sent us always indicated that she was stable, feeling very well and with no news about the tumor.
In April 2019, 1 year and 6 months into treatment with LifEscozul alone, Reyna was asked to have a thyroid ultrasound to determine where we really stood with respect to the tumor.
These exams reported that the size of the thyroid, even with the presence of the tumor, was 41x14x24mm, with a slight decrease in the size of the thyroid.
This, together with the quality of life and the non-development of metastasis, we consider an achievement.
The decision to follow one treatment or another is entirely up to the patient. We can, as specialists, provide our recommendation as physicians.
Reyna made the decision to only treat with LifEscozul, the formulation based on the active ingredient of the blue scorpion venom (escozul).
To date, after two years of treatment, the pain has disappeared, her quality of life has been maintained and the tumor has slightly decreased.
In general Reyna does not seem to be going through this disease. As you can see in the video accompanying this article, her condition is very good.
Any decision made by the patient will be respected by LifEscozul Group, our role will always be to support and achieve results above all else.
In Reyna's case, this has been the case and the results speak for themselves.
We are the LifEscozul Group and the results define us.
Lenin Alvia Cusme
Lenin had undergone surgery in July 2014 for a high grade astrocytoma with partial resection. After surgery he received radiotherapy between November and January 2015, and chemotherapy with temozolamide. After surgery the doctors established that he was left with a general disability of 70% and 40% of speech. In addition, he was given a survival period of 1 to 2 years, since for this type of case there is a high probability that the tumor will develop again and be much more aggressive. View more